For help on how to get the results you want, see our search tips.
1496 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Direct healthcare professional communication Remove Direct healthcare professional communication filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Adrovance (updated)
alendronate sodium trihydrate, colecalciferol, Osteoporosis, Postmenopausal
Date of authorisation: 04/01/2007, Revision: 21, Authorised, Last updated: 22/10/2020 -
List item
Human medicine European public assessment report (EPAR): Rasagiline ratiopharm (updated)
rasagiline, Parkinson Disease
Date of authorisation: 12/01/2015, Revision: 7, Authorised, Last updated: 22/10/2020 -
List item
Human medicine European public assessment report (EPAR): Beovu (updated)
brolucizumab, Wet Macular Degeneration
Date of authorisation: 13/02/2020,
, Revision: 1, Authorised, Last updated: 22/10/2020
-
List item
Human medicine European public assessment report (EPAR): Azilect (updated)
rasagiline, Parkinson Disease
Date of authorisation: 21/02/2005, Revision: 21, Authorised, Last updated: 22/10/2020 -
List item
Human medicine European public assessment report (EPAR): Briviact (in Italy: Nubriveo) (updated)
Brivaracetam, Epilepsy
Date of authorisation: 13/01/2016,, Revision: 9, Authorised, Last updated: 22/10/2020
-
List item
Human medicine European public assessment report (EPAR): Glyxambi (updated)
empagliflozin, linagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 11/11/2016,, Revision: 10, Authorised, Last updated: 22/10/2020
-
List item
Human medicine European public assessment report (EPAR): Sunosi (updated)
solriamfetol hydrochloride, Narcolepsy, Sleep Apnea, Obstructive
Date of authorisation: 16/01/2020,, Revision: 1, Authorised, Last updated: 22/10/2020
-
List item
Human medicine European public assessment report (EPAR): Zoledronic acid Actavis (updated)
zoledronic acid monohydrate, Fractures, Bone
Date of authorisation: 20/04/2012,
, Revision: 13, Authorised, Last updated: 22/10/2020
-
List item
Human medicine European public assessment report (EPAR): Jalra (updated)
vildagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 18/11/2008, Revision: 20, Authorised, Last updated: 22/10/2020 -
List item
Human medicine European public assessment report (EPAR): Feraccru (updated)
ferric maltol, Anemia, Iron-Deficiency
Date of authorisation: 18/02/2016, Revision: 11, Authorised, Last updated: 22/10/2020 -
List item
Human medicine European public assessment report (EPAR): Luminity (updated)
perflutren, Echocardiography
Date of authorisation: 20/09/2006, Revision: 14, Authorised, Last updated: 22/10/2020 -
List item
Human medicine European public assessment report (EPAR): Efient (updated)
prasugrel, Acute Coronary Syndrome, Angina, Unstable, Myocardial Infarction
Date of authorisation: 24/02/2009, Revision: 21, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Synjardy (updated)
empagliflozin, metformin, Diabetes Mellitus, Type 2
Date of authorisation: 27/05/2015,, Revision: 17, Authorised, Last updated: 21/10/2020
-
List item
Human medicine European public assessment report (EPAR): Jardiance (updated)
empagliflozin, Diabetes Mellitus, Type 2
Date of authorisation: 22/05/2014, Revision: 19, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Duavive (updated)
oestrogens conjugated, bazedoxifene, Postmenopause
Date of authorisation: 16/12/2014, Revision: 11, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Edistride (updated)
dapagliflozin propanediol monohydrate, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
Date of authorisation: 09/11/2015, Revision: 13, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Aubagio (updated)
Teriflunomide, Multiple Sclerosis
Date of authorisation: 26/08/2013, Revision: 16, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Carmustine Obvius (updated)
carmustine, Hodgkin Disease, Lymphoma, Non-Hodgkin
Date of authorisation: 18/07/2018,, Revision: 5, Authorised, Last updated: 21/10/2020
-
List item
Human medicine European public assessment report (EPAR): Ristfor (updated)
sitagliptin, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/03/2010, Revision: 20, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Aripiprazole Accord (updated)
aripiprazole, Schizophrenia, Bipolar Disorder
Date of authorisation: 15/11/2015,, Revision: 11, Authorised, Last updated: 21/10/2020
-
List item
Human medicine European public assessment report (EPAR): Eptifibatide Accord (updated)
eptifibatide, Myocardial Infarction
Date of authorisation: 11/01/2016,, Revision: 3, Authorised, Last updated: 21/10/2020
-
List item
Human medicine European public assessment report (EPAR): Hemangiol (updated)
propranolol hydrochloride, Hemangioma
Date of authorisation: 23/04/2014, Revision: 5, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Actrapid (updated)
human insulin, Diabetes Mellitus
Date of authorisation: 07/10/2002, Revision: 17, Authorised, Last updated: 21/10/2020 -
List item
Human medicine European public assessment report (EPAR): Pregabalin Pfizer (updated)
pregabalin, Anxiety Disorders, Epilepsy
Date of authorisation: 10/04/2014, Revision: 20, Authorised, Last updated: 20/10/2020 -
List item
Human medicine European public assessment report (EPAR): SomaKit TOC (updated)
edotreotide, Neuroendocrine Tumors, Radionuclide Imaging
Date of authorisation: 08/12/2016,, 
, Revision: 6, Authorised, Last updated: 20/10/2020